These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32215915)

  • 1. Cross-talk between dopamine D1 and corticotropin releasing factor type 2 receptors leads to occlusion of their ERK1/2 signaling.
    Yarur HE; González MP; Verbel-Vergara D; Andrés ME; Gysling K
    J Neurochem; 2020 Nov; 155(3):264-273. PubMed ID: 32215915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells.
    Fuenzalida J; Galaz P; Araya KA; Slater PG; Blanco EH; Campusano JM; Ciruela F; Gysling K
    Br J Pharmacol; 2014 Dec; 171(24):5650-64. PubMed ID: 25073922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Interplay of Type-2 Corticotrophin Releasing Factor and Dopamine Receptors in the Basolateral Amygdala-Medial Prefrontal Cortex Circuitry.
    Yarur HE; Zegers J; Vega-Quiroga I; Novoa J; Ciruela F; Andres ME; Gysling K
    Int J Neuropsychopharmacol; 2021 Mar; 24(3):221-228. PubMed ID: 33125479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells.
    Yarur HE; Andrés ME; Gysling K
    Front Pharmacol; 2019; 10():1501. PubMed ID: 31969820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
    Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
    Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased G Protein-Independent Signaling of Dopamine D
    Guitart X; Moreno E; Rea W; Sánchez-Soto M; Cai NS; Quiroz C; Kumar V; Bourque L; Cortés A; Canela EI; Bishop C; Newman AH; Casadó V; Ferré S
    Mol Neurobiol; 2019 Oct; 56(10):6756-6769. PubMed ID: 30919214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological targeting of G protein-coupled receptor heteromers.
    Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
    Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of amphetamine over the corticotropin-releasing factor CRF
    Navarro G; Medrano M; Aguinaga D; Vega-Quiroga I; Lillo A; Jiménez J; Casanovas M; Canela EI; Mallol J; Gysling K; Franco R
    Neuropharmacology; 2019 Jul; 152():102-111. PubMed ID: 30465812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction.
    Fanni S; Scheggi S; Rossi F; Tronci E; Traccis F; Stancampiano R; De Montis MG; Devoto P; Gambarana C; Bortolato M; Frau R; Carta M
    Neurobiol Dis; 2019 Jan; 121():120-130. PubMed ID: 30261284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteroreceptor Complexes Formed by Dopamine D
    Rodríguez-Ruiz M; Moreno E; Moreno-Delgado D; Navarro G; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Franco R
    Mol Neurobiol; 2017 Aug; 54(6):4537-4550. PubMed ID: 27370794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in effort-related decision-making induced by stimulation of dopamine D
    Bryce CA; Floresco SB
    Psychopharmacology (Berl); 2019 Sep; 236(9):2699-2712. PubMed ID: 30972447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K; Matsokis N; Angelatou F
    Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease.
    Fiorentini C; Savoia P; Savoldi D; Barbon A; Missale C
    Neurobiol Dis; 2013 Jun; 54():339-48. PubMed ID: 23328768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade.
    Chen J; Rusnak M; Luedtke RR; Sidhu A
    J Biol Chem; 2004 Sep; 279(38):39317-30. PubMed ID: 15247297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells.
    Khan F; Spicarová Z; Zelenin S; Holtbäck U; Scott L; Aperia A
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1110-6. PubMed ID: 18701624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Electroacupuncture on Expression of D1 Receptor (D1R), Phosphorylation of Extracellular-Regulated Protein Kinase 1/2 (p-ERK1/2), and c-Fos in the Insular Cortex of Ketamine-Addicted Rats.
    Wu F; Ding J; Li HB; Miao HC; Bao R; Yang S
    Med Sci Monit Basic Res; 2019 Jan; 25():26-32. PubMed ID: 30700692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala.
    Miyata I; Shiota C; Ikeda Y; Oshida Y; Chaki S; Okuyama S; Inagami T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):692-6. PubMed ID: 10080961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
    Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
    Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses.
    Ladepeche L; Yang L; Bouchet D; Groc L
    PLoS One; 2013; 8(9):e74512. PubMed ID: 24040266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.